-
中国抗癌协会乳腺癌诊治指南与规范(2011版),中国抗癌协会乳腺癌专业委员会 - 中国癌症杂志,2011. 21(5): 367-417
-
乳腺癌临床实践指南(中国版)2010 年第一版(源自英文版V.2.2010)。 Available from: www.nccn.org
-
乳腺癌诊疗规范(2011年版)-卫生部(www.moh.gov.cn)
-
现代肿瘤学(第三版) - 复旦大学出版社,2011年7月,第890-931页(主编:汤钊猷)
-
Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. http://www.springer.com/ medicine/surgery/cancer+staging?SGWID=0-40654-0-0-0. Accessed 12 Mar 2010
-
Geyer CE, Forster J, Lindquist D, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006 Dec;355(26):2733-2743.
PMID: 17192538
-
Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007 Jul;18(7):1133-1144.
PMID: 17675394
-
Kataja V, Castiglione M; ESMO Guidelines Working Group. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2009 May;20(Suppl 4):10-14. doi: 10.1093/annonc/mdp114.
PMID: 19454421
-
LHRH-agonists in Early Breast Cancer Overview group, Cuzick J, Ambroisine L, Davidson N, et al. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials. Lancet. 2007 May;369(9574):1711-1723.
PMID: 17512856
-
Ministry of Health Malaysia, Academy of Medicine. Clinical practice guidelines. Management of breast cancer. http://acadmed.org.my/cpg/CPGManagement% 20of%20Ca%20Breast.pdf. Dec 2002
-
National Collaborating Centre for Cancer. Advanced breast cancer: diagnosis and treatment. http://www.nice.org.uk. Feb 2009. Accessed 11 Mar 2010.
-
National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment. http://www.nice.org.uk. Feb 2009. Accessed 11 Mar 2010.
-
National Collaborating Centre for Primary Care. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. http://www.nice.org.uk/nicemedia/pdf/ CG41fullguidance.pdf. Jul 2006. Accessed 11 Mar 2010
-
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Breast cancer risk reduction. Ver 2. NCCN. http://www.nccn.org/professionals/physician_gls/PDF/breast_risk.pdf. 2009. Accessed 11 Mar 2010
-
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Breast cancer screening and diagnosis guidelines. Ver 1. NCCN. http://www.nccn.org/professionals/physician_gls/PDF/breast-screening.pdf. 2010. Accessed 11 Mar 2010
-
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Breast cancer. Ver 1. NCCN. http://www.nccn.org/professionals/physician_gls/PDF/breast.pd. 2010. Accessed 11 Mar 2010
-
National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology. Breast cancer. Ver 1. NCCN. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. 2011. Accessed 12 Nov 2010
-
National Institute for Health and Care Excellence. Guidance on cancer services: improving outcomes in breast cancer manual update. NICE. http://www.nice.org.uk/nicemedia/pdf/Improving_outcomes_breastcancer_manual.pdf. Aug 2002. Accessed 11 Mar 2010
-
Walter Jonat, Michael Gnant, Francesco Boccardo, et al. Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. The Lancet Oncology. http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2806%2970948-2/abstract. Dec 2006
|